MeSH D011528 - protozoan infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010272:Parasitic diseases
0 Companies
0 Drugs
Success rate
D011528:Â
Protozoan infections
D000562:Amebiasis
D001404:Babesiosis
D003048:Coccidiosis
0 Companies
0 Drugs
Success rate
D004030:Dientamoebiasis
0 Companies
0 Drugs
Success rate
D005873:Giardiasis
D008288:Malaria
D011529:Animal protozoan infections
0 Companies
0 Drugs
Success rate
D013801:Theileriasis
0 Companies
0 Drugs
Success rate
D014245:Trichomonas infections
0 Companies
0 Drugs
Success rate
D016770:Ciliophora infections
0 Companies
0 Drugs
Success rate
D020808:Central nervous system protozoal infections
0 Companies
0 Drugs
Success rate
D056986:Euglenozoa infections
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Rising Pharmaceuticals | Nitazoxanide | Nitazoxanide |  | 2020-11-27 |  |  |
| Erythromycin, Benzoyl peroxide | Erythromycin Benzoyl Peroxide |  | 2015-09-18 |  |  |
1
2
3
4
5
6
...
17
>
Clinical Trials
Historical Success Rate
Phase 1
33%2/6
Phase 2
0%0/2
Phase 3
96%26/27
Approved: 26Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
11
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use